×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1800 Total Publications

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
Hu, W. T., Holtzman, D. M., Fagan, A. M., Shaw, L. M., Perrin, R., Arnold, S. E., … Soares, H.
PMID: 22855860 ; PMCID:3425844 ; 2012; Journal Neurology; vol. 79; no. 9; pp. 897-905; AWTYIuKfwAl_G9zjEvZA doi:10.1212/WNL.0b013e318266fa70
Comparison of Imaging Biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging
Whitwell, J. L., Wiste, H. J., Weigand, S. D., Rocca, W. A., Knopman, D. S., Roberts, R. O., … Jack, C. R.
PMID: 22782510 ; PMCID:3569033 ; 2012; Journal JAMA Neurology; vol. 69; no. 5; pp. 614-22; AWTX9JHXwAl_G9zjEvXu doi:10.1001/archneurol.2011.3029
Cortical folding analysis on patients with Alzheimer's disease and mild cognitive impairment.
Cash, D. M., Melbourne, A., Modat, M., Cardoso, M. J., Clarkson, M. J., Fox, N. C., & Ourselin, S.
PMID: 23286142 ; 2012; Journal Medical Image Computing and Computer-Assisted Intervention; vol. 15; no. 3; pp. 289-296; AWTX9JHXwAl_G9zjEvX3
Advanced Psychometric Analysis and the Alzheimer’s Disease Neuroimaging Initiative:Reports from the 2011 Friday Harbor Conference
Mungas D1, Crane PK, Gibbons LE, Manly JJ, Glymour MM, Jones RN
PMID: 23232798 ; PMCID:3532555 ; 2012; Journal Brain Imaging Behav; vol. 6; no. 4; pp. 485-8; AWTYO_KSMOwVf_qbJr6j doi:10.1007/s11682-012-9211-2
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
Soares, H. D., Potter, W. Z., Pickering, E., Kuhn, M., Immermann, F. W., Shera, D. M., … Shaw, L. M.
PMID: 22801723 ; PMCID:3683865 ; 2012; Journal JAMA Neurology; vol. 69; no. 10; pp. 1310-7; AWTYkYsdwAl_G9zjEvc7 doi:10.1001/archneurol.2012.1070
Vascular burden and Alzheimer disease pathologic progression.
Lo, R. Y., & Jagust, W. J.
2012; Journal Neurology; vol. 79; no. 13; pp. 1349-1355; AWURO74rdzjauPDbjhp- doi:10.1212/WNL.0b013e31826c1b9d
Genome-wide association study of Alzheimer’s disease.
Kamboh, M. I., Demirci, F. Y., Wang, X., Minster, R. L., Carrasquillo, M. M., Pankratz, V. S., … Barmada, M. M.
2012; Journal Translational Psychiatry; vol. 2; no. 5; pp. e117; AWURO74rdzjauPDbjhqB doi:10.1038/tp.2012.45
Combining patient-level and summary-level data for Alzheimer’s disease modeling and simulation: a β regression meta-analysis.
Rogers, J. A., Polhamus, D., Gillespie, W. R., Ito, K., Romero, K., Qiu, R., … Corrigan, B.
2012; Journal Journal of Pharmacokinetics and Pharmacodynamics; vol. 39; no. 5; pp. 479-98; AWURPm3fwAl_G9zjEvgB doi:10.1007/s10928-012-9263-3
Predicting missing biomarker data in a longitudinal study of Alzheimer disease.
Lo, R. Y., & Jagust, W. J.
2012; Journal Neurology; vol. 78; no. 18; pp. 1376-82; AWURPm3fwAl_G9zjEvgG doi:10.1212/WNL.0b013e318253d5b3